These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2776053)

  • 1. [Clinical analysis of bone diseases in patients under chronic hemopurification].
    Zhu LY
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):128-30, 10. PubMed ID: 2776053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum load and histological bone disease in hemofiltration and hemodialysis.
    Fournier A; Moriniere P; Fohrer P; Leflon P; de Fremont JF; Marié A; Westeel PF; Renaud H; Tahiri Y; Idrissi A
    Kidney Int Suppl; 1988 Mar; 24():S168-70. PubMed ID: 3163040
    [No Abstract]   [Full Text] [Related]  

  • 4. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
    Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
    Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skeletal and soft part changes in patients on chronic dialysis].
    Herrmann K; Krohs G
    Z Gesamte Inn Med; 1974 Nov; 29(21):891-5. PubMed ID: 4462343
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical aspects and applications of hemofiltration.
    Weiss LG
    Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1358-65. PubMed ID: 11032503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of aluminum gels on renal osteodystrophy caused by chronic hemodialysis. Increase in the total surface of osseous resorption in anephric patients].
    Fournier A; Tunchot S; Bedrossians J; Idatte JM; Bordier P
    Sem Hop; 1974 Nov; 50(45):2803-10. PubMed ID: 4375854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J; Brunfaut C
    J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P; Gmeiner R; Beck G; König P
    Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bone mineral content during long-term CAPD. Indication of a sex-dependent bone mineral loss.
    Lyhne N; Pedersen FB
    Nephrol Dial Transplant; 1995; 10(3):395-8. PubMed ID: 7792038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rheumatologic and radiologic symptoms of secondary hyperparathyroidism: retrospective long-term study of 175 chronic hemodialysis patients].
    Mayet WJ; Hermann E; Wandel E; Elsen A; Schadmand S; Klose KJ; Poralla T; Meyer zum Büschenfelde KH; Köhler H
    Z Rheumatol; 1991; 50(5):313-9. PubMed ID: 1776368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings in bones following dialyses and kidney transplantation.
    Kolár J
    Acta Univ Carol Med (Praha); 1970; 16(5):487-501. PubMed ID: 4934660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.